340B: Latest Trends and Developments
About this episode
This episode discusses the current legal and regulatory landscape of the 340B program with insights from industry experts.
Greg Doggett, Counsel, Powers Pyles Sutter & Verville PC, and Felicity Homsted, CEO, FQHC 340B Compliance, discuss the current legal and regulatory landscape of the 340B program. They cover the intersection of 340B with the Inflation Reduction Act, concerns about the Rebate Model, pharmaceutical manufacturer restrictions and data requirements for covered entities, AbbVie’s patient definition lawsuit, state reporting requirements, and potential Congressional action. Watch this episode: htt...
More episodes of AHLA's Speaking of Health Law
- States' Renewed Focus on Corporate Practice of Medicine and Its Impact on Health Care Transactions
- One Year In: Implementing the Medicaid Provisions of the Working Families Tax Cut Act
- Distressed Health Care Providers—Key Restructuring Issues for 2026
- Audit Defense: What Health Care Providers and Attorneys Need to Know
- Health Care Corporate Governance: Seeking Clarity on the Role Description of the Board Chair
- CMMI and the Next Generation of Alternative Payment Models
Explore listener stats, chart rankings, contacts and more on the AHLA's Speaking of Health Law podcast page.